Introduction Pemphigus vulgaris (PV) is a chronic, autoimmune, vesiculobullous disease. As
a result of the relative rarity of PV, published randomized controlled trials (RCTs) are limited …

Pemphigus is an autoimmune blistering disease characterized by cutaneous and mucosal
blisters and erosions. Though systemic corticosteroids have been the mainstay of treatment …

Aim: Bullous pemphigoid (BP) is an organ-specific autoimmune bullous disease
characterized by autoantibodies that target the cellular adhesion molecules BP180 and …

Objective This study aimed to investigate the clinical features of biologics-induced bullous
pemphigoid (BP) and the therapeutic effects of those agents for BP, exploring the underlying …

Pemphigus is a group of rare and potentially fatal autoimmune blistering diseases that are
associated with auto-antibodies that target intercellular adhesion molecules. Incidence of …

Pemphigus vulgaris is an autoimmune blistering disease with an increased potential for
mortality. The epithelium is key in understanding the pathobiology as it is specialized to …

Several case reports and cohort studies have recently investigated the potential association
between bullous pemphigoid (BP) and psoriasis. It has been speculated that chronic …

Background TH 2 cells were thought to be a pivotal factor for initiation of the autoimmune
blistering disease pemphigus. However, the role of other T-cell subsets in pemphigus …

Introduction Pemphigus encompasses a group of muco-cutaneous autoimmune bullous
diseases characterized by the loss of adhesion between keratinocytes. The disease is …

Pemphigus is a group of autoimmune blistering diseases caused by antibodies against
desmogleins 1 and 3 (Dsg1 and Dsg3, respectively), which are adhesion molecules …